Published in Clin Endocrinol (Oxf) on July 01, 1974
Antenatal maternal serum screening for Down's syndrome: results of a demonstration project. BMJ (1992) 9.08
Maternal serum screening for Down's syndrome in early pregnancy. BMJ (1988) 8.65
A radioimmunoassay for rat plasma ACTH. Endocrinology (1971) 3.35
Season of initial discovery of tumour as an independent variable predicting survival in breast cancer. Br J Cancer (1990) 2.55
Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study. Int J Epidemiol (1990) 2.46
Vasopressin analogue DDAVP in diabetes insipidus: clinical and laboratory studies. Br Med J (1973) 2.41
Long-term treatment of acromegaly with bromocriptine. Br Med J (1977) 2.18
Galactorrhoea: successful treatment with reduction of plasma prolactin levels by brom-ergocryptine. Br Med J (1972) 2.07
Measurement of dimeric inhibin B throughout the human menstrual cycle. J Clin Endocrinol Metab (1996) 2.06
Long-term treatment of galactorrhoea and hypogonadism with bromocriptine. Br Med J (1974) 1.98
Increased beta-endorphin but not met-enkephalin levels in human cerebrospinal fluid after acupuncture for recurrent pain. Lancet (1980) 1.94
Cloning and characterization of cDNAs encoding human gastrin-releasing peptide. Proc Natl Acad Sci U S A (1984) 1.93
A possible role for prolactin in control of steroid secretion by the human Graafian follicle. Nature (1974) 1.92
Placental lactogen levels as a screening test for fetal distress and neonatal asphyxia. Lancet (1972) 1.85
Radioimmunoassay of human prolactin. Proc R Soc Med (1973) 1.81
Microcomputers in antenatal care: a feasibility study on the booking interview. Br Med J (Clin Res Ed) (1981) 1.70
Action of growth-hormone-release inhibitory hormone in healthy men and in acromegaly. Lancet (1973) 1.68
Levels of alpha-fetoprotein in maternal blood as a screening test for fetal neural-tube defect. Lancet (1975) 1.67
Luteinizing hormone and follicle stimulating hormone-releasing hormone test in patients with hypothalamic-pituitary-gonadal dysfunction. Br Med J (1973) 1.66
Diagnosis and management of ACTH-dependent Cushing's syndrome: comparison of the features in ectopic and pituitary ACTH production. Clin Endocrinol (Oxf) (1986) 1.62
Interaction between secretion of the gonadotrophins, prolactin, growth hormone, thyrotrophin and corticosteroids in man: the effects of LH FSH-RH, TRH and hypoglycaemia alone and in combination. Clin Endocrinol (Oxf) (1973) 1.60
Reactive glia express cytosolic phospholipase A2 after transient global forebrain ischemia in the rat. Stroke (1996) 1.59
Inhibin-B: a likely candidate for the physiologically important form of inhibin in men. J Clin Endocrinol Metab (1996) 1.59
Consensus statement on the use of breastfeeding as a family planning method. Contraception (1989) 1.59
Ectopic hormone production by non-endocrine tumours. Clin Endocrinol (Oxf) (1974) 1.56
Lung tumours and ACTH production. Clin Endocrinol (Oxf) (1977) 1.54
A rapid radioimmunoassay for human chorionic somatomammotrophin. J Obstet Gynaecol Br Commonw (1971) 1.54
Cell type-specific adenoviral transgene expression in the intact ovine pituitary gland after stereotaxic delivery: an in vivo system for long-term multiple parameter evaluation of human pituitary gene therapy. Endocrinology (2001) 1.52
Decreased inhibin B secretion is associated with the monotropic FSH rise in older, ovulatory women: a study of serum and follicular fluid levels of dimeric inhibin A and B in spontaneous menstrual cycles. J Clin Endocrinol Metab (1996) 1.52
Letter: Metaclopramide and prolactin. Br Med J (1974) 1.48
A reappraisal of human beta MSH. Nature (1974) 1.46
Hypothalamic-pituitary-prolactin axis in breast cancer. Lancet (1974) 1.45
Cushing's syndrome. Clin Endocrinol Metab (1985) 1.44
Metformin decreases GnRH- and activin-induced gonadotropin secretion in rat pituitary cells: potential involvement of adenosine 5' monophosphate-activated protein kinase (PRKA). Biol Reprod (2010) 1.43
The acromegalic rosary. Lancet (1991) 1.43
The development of a radioimmunoassay for oxytocin: the extraction of oxytocin from urine and determination of the excretion rate for exogenous and endogenous oxytocin in human urine. J Endocrinol (1972) 1.43
Early amniocentesis: alphafetoprotein levels in amniotic fluid, extraembryonic coelomic fluid and maternal serum between 8 and 13 weeks. Br J Obstet Gynaecol (1991) 1.42
Lack of evidence for a circadian rhythm of IGFBP-1 in the mother and fetus during labour. Br J Obstet Gynaecol (1995) 1.41
Determinants of clinical outcome and survival in acromegaly. Clin Endocrinol (Oxf) (1994) 1.40
The relationship between serum prolactin and immunocytochemical staining for prolactin in patients with pituitary macroadenomas. Clin Endocrinol (Oxf) (1985) 1.40
Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A. Clin Endocrinol (Oxf) (1996) 1.40
Crown-rump length in aneuploid fetuses: implications for first-trimester biochemical screening for aneuploidies. Prenat Diagn (1995) 1.39
Pituitary peptide. Nat New Biol (1973) 1.39
Prolactin, TSH, LH and FSH responses to a combined LHRH-TRH test at different stages of the menstrual cycle. Clin Endocrinol (Oxf) (1974) 1.37
Variation in receptor status between primary and metastatic breast cancer. Cancer (1983) 1.36
Bromocriptine in management of large pituitary tumours. Br Med J (Clin Res Ed) (1982) 1.36
The incidence of impacted teeth. A survey at Harlem hospital. Oral Surg Oral Med Oral Pathol (1970) 1.35
Simplified method for measuring sex-hormone binding globulin. Clin Chem (1981) 1.35
The development of a radioimmunoassay for oxytocin: the extraction of oxytocin from plasma, and its measurement during parturition in human and goat blood. J Endocrinol (1970) 1.35
Detection of dimeric inhibin throughout the human menstrual cycle by two-site enzyme immunoassay. Clin Endocrinol (Oxf) (1994) 1.32
ACTH, lipotrophin and MSH in health and disease. Clin Endocrinol Metab (1977) 1.32
Progesterone and estrogen receptors as prognostic variables in breast cancer. Cancer Res (1983) 1.31
Cyclical combination chemotherapy and gonadal function. Retrospective study in males. Lancet (1979) 1.31
Specific and sensitive determination of pregnancy-specific beta 1-glycoprotein by radioimmunoassay. A new pregnancy test. Lancet (1977) 1.31
Development of a specific extracted radioimmunoassay for methionine enkephalin in human plasma and cerebrospinal fluid. J Endocrinol (1980) 1.31
A rapid semi-automated method for the measurement of human chorionic somatomammotrophin. The normal range in the third trimester and its relation to fetal weight. J Obstet Gynaecol Br Commonw (1971) 1.30
Development and validation of a radioimmunoassay for peptides related to beta-melanocyte-stimulating hormone in human plasma: the lipotropins. J Clin Endocrinol Metab (1975) 1.30
Theca: the forgotten cell of the ovarian follicle. Reproduction (2010) 1.29
The development of a radioimmunoassay and a plasma extraction method for vasopressin. J Endocrinol (1970) 1.28
The biosynthesis of hormones by non-endocrine tumours--a review. J Endocrinol (1975) 1.27
Development and validation of a specific radioimmunoassay for somatostatin in human plasma. Ann Clin Biochem (1979) 1.26
beta-Endorphin in human cerebrospinal fluid. Lancet (1978) 1.26
Placental lactogen levels as guide to outcome of threatened abortion. Br Med J (1972) 1.24
Identification of the mechanism for the inhibition of Na+,K(+)-adenosine triphosphatase by hyperglycemia involving activation of protein kinase C and cytosolic phospholipase A2. J Clin Invest (1995) 1.24
Met-enkephalin circulates in human plasma. Nature (1980) 1.23
Acupuncture in heroin addicts; changes in Met-enkephalin and beta-endorphin in blood and cerebrospinal fluid. Lancet (1979) 1.22
Serum inhibin B levels reflect Sertoli cell function in normal men and men with testicular dysfunction. J Clin Endocrinol Metab (1996) 1.20
Strengths and weaknesses of direct patient interviewing by a microcomputer system in specialist gynaecological practice. Eur J Obstet Gynecol Reprod Biol (1984) 1.20
Molecular cloning of two new human paralogs of 85-kDa cytosolic phospholipase A2. J Biol Chem (1999) 1.19
Metyrapone in long-term management of Cushing's disease. Br Med J (1977) 1.19
The effects of beta-human chorionic gonadotrophin on the in vitro growth of bladder cancer cell lines. Br J Cancer (1996) 1.19
The development of on-line history-taking systems in antenatal care. Methods Inf Med (1983) 1.18
Hormonal responses to synthetic luteinizing hormone and follicle stimulating hormone-releasing hormone in man. Br Med J (1972) 1.17
Concentrations of pregnancy-specific beta 1-glycoprotein in maternal blood in normal pregnancy and in intrauterine growth retardation. Lancet (1977) 1.17
Identification of essential residues for the catalytic function of 85-kDa cytosolic phospholipase A2. Probing the role of histidine, aspartic acid, cysteine, and arginine. J Biol Chem (1996) 1.16
The Booroola (FecB) phenotype is associated with a mutation in the bone morphogenetic receptor type 1 B (BMPR1B) gene. J Endocrinol (2001) 1.16
Phosphorylation and activation of cytosolic phospholipase A2 by 38-kDa mitogen-activated protein kinase in collagen-stimulated human platelets. Eur J Biochem (1997) 1.15
Corticotrophin releasing factor: responses in normal subjects and patients with disorders of the hypothalamus and pituitary. Clin Endocrinol (Oxf) (1984) 1.15
Metal ion and salt effects on the phospholipase A2, lysophospholipase, and transacylase activities of human cytosolic phospholipase A2. Biochim Biophys Acta (1993) 1.14
Audit of compliance with antenatal protocols. BMJ (1992) 1.13
Structure of recombinant human rheumatoid arthritic synovial fluid phospholipase A2 at 2.2 A resolution. Nature (1991) 1.13
Arachidonoyl transacylase in human platelets. Coenzyme A-independent transfer of arachidonate from phosphatidylcholine to lysoplasmenylethanolamine. J Biol Chem (1983) 1.13
An unusual cause of hyperinsulinaemic hypoglycaemia syndrome. Diabet Med (2003) 1.12
Alcohol-induced pseudo-Cushing's syndrome. Lancet (1977) 1.12
Release of oxytocin and prolactin in response to suckling. Br Med J (Clin Res Ed) (1983) 1.12
The interaction of growth hormone releasing hormone with other hypothalamic hormones on the release of anterior pituitary hormones. Clin Endocrinol (Oxf) (1986) 1.12
Interpretation of single progesterone measurement in diagnosis of anovulation and defective luteal phase: observations on analysis of the normal range. Br Med J (Clin Res Ed) (1984) 1.10
Serum fructosamine concentration as measure of blood glucose control in type I (insulin dependent) diabetes mellitus. Br Med J (Clin Res Ed) (1985) 1.10
Plasma immunoreactive corticotrophin and lipotrophin in Cushing's syndrome and Addison's disease. Br Med J (1977) 1.10
Isolated pituitary gonadotrophin deficiency: gonadotrophin secretion after synthetic luteinizing hormone and follicle stimulation hormone-releasing hormone. Br Med J (1972) 1.10
Clinical significance of plasma chlorpromazine levels. I. Plasma levels of the drug, some of its metabolites and prolactin during acute treatment. Psychol Med (1976) 1.10
Circadian variation of GH-independent IGF-binding protein in diabetes mellitus and its relationship to insulin. A new role for insulin? Clin Endocrinol (Oxf) (1988) 1.10
Dipstick method for human chorionic gonadotropin suitable for emergency use on whole blood and other fluids. Lancet (1985) 1.09
Overall survival from breast cancer in women pregnant or lactating at or after diagnosis. Auckland Breast Cancer Study Group. Int J Cancer (1996) 1.09
Cytosolic phospholipase A2 is phosphorylated in collagen- and thrombin-stimulated human platelets independent of protein kinase C and mitogen-activated protein kinase. J Biol Chem (1995) 1.09